Structured evidence table for Acetyl-L-Carnitine Mood Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Acetyl-L-Carnitine Mood Meta-Analysis | In summary, current clinical and preclinical evidence supports the antidepressant properties of acetyl-L-carnitine, particularly in populations with treatment-resistant depression, and cognitive impairment in mood disturbances. | 1 | Kumar Rakesh (2026) | Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis |
| Acetyl-L-Carnitine Mood Meta-Analysis | There is a lack of consistent data and evidence regarding an optimal use of ALC in treatment of depression. | 1 | Kumar Rakesh (2026) | Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis |
| Acetyl-L-Carnitine Mood Meta-Analysis | Thus, we aimed to conduct this systematic review to appraise the current evidence for ALC use in the treatment of depression in mood disorders. | 1 | Kumar Rakesh (2026) | Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis |
| Acetyl-L-Carnitine Mood Meta-Analysis | 2 5 6–9 Despite the availability of multiple antidepressant classes, TRD remains common, and many patients experience incomplete remission or intolerable side effects.,These limitations underscore the urgent need for newer approaches to broaden MDD/TRD treatment options. | 1 | Kumar Rakesh (2026) | Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis |
| Acetyl-L-Carnitine Mood Meta-Analysis | However, a timely diagnosis of MDD is key, as delay means it takes longer to receive adequate treatment, a worse prognosis, increased patient burden and higher healthcare costs. | 4 | Jentsch Mike C. (2026) | Feasibility of diagnosing major depressive disorder with a panel of serum and urine biomarkers |
| Acetyl-L-Carnitine Mood Meta-Analysis | Ethnicity was recorded using the different intake questionnaires administered in the various studies, according to the procedures described in the associated publications. | 4 | Jentsch Mike C. (2026) | Feasibility of diagnosing major depressive disorder with a panel of serum and urine biomarkers |
| Acetyl-L-Carnitine Mood Meta-Analysis | The full description for calculating the RVI can be found within Supplementary File. | 4 | Jentsch Mike C. (2026) | Feasibility of diagnosing major depressive disorder with a panel of serum and urine biomarkers |
| Acetyl-L-Carnitine Mood Meta-Analysis | 5 7 – Symptoms of MDD have considerable overlap with other psychiatric and physical disorders, making an accurate differential diagnosis challenging. | 4 | Jentsch Mike C. (2026) | Feasibility of diagnosing major depressive disorder with a panel of serum and urine biomarkers |
Source documents